Nir Barzilai — SPARQNOW

At-a-Glance

Director, Einstein Institute for Geroscience and the BIO VITAL program at Albert Einstein College of Medicine.
Co-founded CohBar, Inc., a biotechnology company developing mitochondria-based therapeutics to treat diseases associated with aging.
Discovered several "longevity genes" in humans, including variants protecting against major age-related diseases.
Directed the Metformin in Longevity Study, which was completed in May 2018.
Authored "Age Later: Secrets of the Healthiest, Sharpest Centenarians" (2020).
Earned his MD from Technion – Israel Institute of Technology in 1985.

Biography

Nir Barzilai is an Israeli geneticist and longevity researcher. He serves as the Director of the Einstein Institute for Geroscience and the BIO VITAL program at Albert Einstein College of Medicine. He is also the founding director of the Institute for Aging Research, the Nathan Shock Center of Excellence in the Basic Biology of Aging, and the Paul F. Glenn Center for the Biology of Human Aging Research at Einstein.